Budesonide formoterol adverse effects
Pro Research Analysisby 
Searched over 200M research papers
Budesonide-Formoterol Adverse Effects: Overview and Incidence
Budesonide-formoterol is widely used for asthma and COPD management. Across large patient populations, the combination is generally well-tolerated, with a low overall incidence of adverse effects. In a study from Kazakhstan, only 5.4% of patients experienced any adverse effects, and most were mild, such as mouth dryness (xerostomia), which was easily managed by rinsing the mouth. Only one patient, with a history of severe drug allergies, experienced a serious reaction (angioedema) that required stopping treatment . Similarly, pharmacovigilance data from Brazil covering over 683,000 patients found that only 0.26% reported adverse events, and most were non-serious. Serious events accounted for just 7% of all reported adverse events, making them rare .
Common Adverse Effects: Oral Candidiasis and Dysphonia
Meta-analyses and clinical trials consistently report that the most common adverse effects of budesonide-formoterol are oral candidiasis (thrush) and dysphonia (voice changes). The risk of these effects is higher compared to placebo or formoterol alone, but similar to budesonide monotherapy. Importantly, the risk of more serious respiratory infections, such as pneumonia or bronchitis, is not increased compared to placebo or other treatments . These local side effects are typical of inhaled corticosteroids and can often be minimized by rinsing the mouth after inhalation Nurpeissov2015Tang2019.
Systemic and Cardiovascular Effects
When compared to salbutamol (a short-acting beta-agonist), repeated doses of budesonide-formoterol result in fewer systemic beta-agonist and cardiovascular side effects, such as changes in heart rate or serum potassium levels. Salbutamol was associated with more adverse events and greater cardiovascular impact in direct comparison studies .
Serious and Rare Adverse Events
Serious adverse events, such as severe allergic reactions, are very rare. In large clinical trials and real-world data, the rates of serious adverse events and discontinuations due to adverse effects are low and comparable to other standard asthma treatments FitzGerald2021Miranda2022. No new safety concerns have been identified in recent studies .
Adverse Effects in Special Populations
Genetic differences, such as ADRB2 polymorphisms, do not appear to significantly affect the risk of adverse events or the tolerability of budesonide-formoterol in patients with COPD .
Budesonide-Formoterol Use in Pregnancy
Animal studies suggest a potential risk for birth defects, such as orofacial clefts and heart defects, when budesonide-formoterol is used during pregnancy. However, these findings are based on experimental models and should be interpreted with caution when considering human risk .
Comparison with Other Asthma Treatments
The overall adverse event profile of budesonide-formoterol is similar to that of daily budesonide alone, with no significant increase in the risk of severe or systemic side effects. The combination is also associated with fewer adverse events than as-needed terbutaline (a reliever medication) FitzGerald2021Tong2021Zetterström2001.
Conclusion
Budesonide-formoterol is generally safe and well-tolerated for asthma and COPD, with most adverse effects being mild and manageable. The most common issues are local, such as oral candidiasis and dysphonia, while serious adverse events are rare. Its safety profile is similar to that of other inhaled corticosteroids, and it is associated with fewer systemic side effects than some alternative reliever medications.
Sources and full results
Most relevant research papers on this topic